Aldeyra Therapeutics, Inc. Uncategorized Contracts & Agreements

16 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Open Market Sale AgreementSM by and between the Company and Jefferies LLC, dated August 1, 2024
Aldeyra Therapeutics, Inc.
2024
Offer Letter Amendment No. 2, effective as of March 23, 2021, between the Registrant and Stephen Machatha, Ph.D
Aldeyra Therapeutics, Inc.
Biotechnology
2022
Offer Letter Amendment No. 1, effective as of January 1, 2018, between the Registrant and Stephen Machatha, Ph.D
Aldeyra Therapeutics, Inc.
Biotechnology
2022
Offer Letter, effective as of October 21, 2015, between the Registrant and Stephen Machatha, Ph.D
Aldeyra Therapeutics, Inc.
Biotechnology
MA
2022
Description of Securities
Aldeyra Therapeutics, Inc.
Biotechnology
2020
Offer Letter, effective as of April 19, 2018, between the Registrant and David McMullin
Aldeyra Therapeutics, Inc.
Biotechnology
MA
2019
Open Market Sale AgreementSM, dated December 28, 2018, by and between Aldeyra Therapeutics, Inc. and Jefferies LLC
Aldeyra Therapeutics, Inc.
Biotechnology
NY
2018
Offer Letter, effective as of July 30, 2018, between the Registrant and Joshua Reed
Aldeyra Therapeutics, Inc.
Biotechnology
MA
2018
ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE, SUITE 320 LEXINGTON, MA 02421 December 15, 2015
Aldeyra Therapeutics, Inc.
Biotechnology
MA
2016
* * * * *
Aldeyra Therapeutics, Inc.
Biotechnology
MA
2014
ALDEXA THERAPEUTICS, INC. February 19, 2014
Aldeyra Therapeutics, Inc.
Biotechnology
2014
ALDEXA THERAPEUTICS, INC. February 19, 2014
Aldeyra Therapeutics, Inc.
Biotechnology
2014
INDEMNITY AGREEMENT
Aldeyra Therapeutics, Inc.
Biotechnology
DE
2014
Shares
Aldeyra Therapeutics, Inc.
Biotechnology
2014
Shares
Aldeyra Therapeutics, Inc.
Biotechnology
2014
INDEMNITY AGREEMENT
Aldeyra Therapeutics, Inc.
Biotechnology
DE
2014